# Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects

> **NCT03776110** · PHASE1 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 48 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** GRT9906 PR tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03776110
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-15
- **Primary completion:** 2005-03-23
- **Final completion:** 2005-03-23
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03776110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03776110, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03776110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*